-
Preclinical data recently demonstrated the extreme sensitivity of BRCA-deficient cells to inhibition of the single-strand repair enzyme poly(ADP-ribose) polymerase (PARP).
-
About 30 years ago (so long ago that I can't remember the exact year), I began to edit a monthly newsletter devoted to reproductive medicine.
-
In this issue: Comparing blood pressure medications, determining optimal length of androgen-deprivation therapy, red yeast rice for LDL reduction, and FDA Actions.
-
-
A large prospective randomized trial (n = 2812 women) was retrospectively analyzed to look at contraceptive efficacy and weight/BMI.
-
The raloxifene use for the heart (RUTH) trial was an international randomized, placebo-controlled trial that enrolled 10,101 postmenopausal women in two groups, one at high risk for coronary heart disease, and one with established coronary heart disease.
-
June seems to have been magnesium sulfate month in both the Obstetrics & Gynecology and American Journal of Obstetrics & Gynecology journals.
-
-
Gaining approvals from 36 IRBs for a multisite, multilingual epidemiologic study of tuberculosis gave Dolly Katz, who serves on the Centers for Disease Control and Prevention's IRB, insight as to what it's like on the other side of the protocol.
-
Some larger research institutions in recent years have taken incremental steps to having an electronic IRB submission, review, and documentation process. But transitioning to a paperless process has been more of a challenge for smaller IRBs and institutions.
